Novel diagnostic biomarkers associated with macrophage-microglia in spinal cord injury

Manyi Zheng1, Yunduo Jiang1, Fangyu Liu1

  • 1The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Heilongjiang, Harbin, China.

Frontiers in Immunology
|September 26, 2025
PubMed
Abstract

Insights

Researchers identified EMP3, GNGT2, and SGPL1 as potential diagnostic biomarkers for spinal cord injury (SCI). These genes are linked to macrophage-microglia (MM) cells and inflammation, offering insights for future SCI treatments.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Spinal cord injury (SCI) causes significant motor and proprioceptive deficits due to central nervous system damage.
  • Activated macrophage-microglia (MM) cells play a crucial role in SCI-related inflammation.
  • Limited research exists on differential gene expression in MM cells before and after SCI, hindering biomarker discovery.

Purpose of the Study:

  • To identify novel diagnostic biomarkers for SCI by analyzing differential gene expression in MM cells.
  • To screen key hub genes associated with SCI using machine learning algorithms.
  • To validate the predictive potential and immune associations of identified genes.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) data for SCI-related differentially expressed gene (DEG) identification.
  • Employed multiple machine learning (ML) algorithms to screen key hub genes.
  • Validated findings using independent datasets, assessed immune cell infiltration, and conducted in vitro SCI modeling with qPCR.

Main Results:

  • Single-cell RNA sequencing identified four MM cell subsets; enrichment analyses linked DEGs to SCI biological processes.
  • Three hub genes (EMP3, GNGT2, SGPL1) were identified as differentially expressed before and after SCI using ML algorithms.
  • Predictive models showed strong performance; gene-immune cell correlation suggested an association with M2 macrophages; in vitro models confirmed elevated EMP3, GNGT2, and SGPL1 expression.

Conclusions:

  • EMP3, GNGT2, and SGPL1 are identified as potential diagnostic biomarkers associated with MM cells in SCI.
  • These findings provide a foundation for understanding their biological roles in SCI.
  • The study paves the way for developing future therapeutic strategies for spinal cord injury.

Related Concept Videos